AI closes the viability gap, turning an impossible concept into a first-time employment opportunity. By lowering the barrier ...
Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...
Absci Corporation (NASDAQ:ABSI) pioneers AI-driven biologic drug creation, advancing biotechnology through innovation.
Revolution Medicines (NASDAQ:RVMD) advances precision-oncology research, frequently appearing in biotechnology discussions ...
In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...
Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...
The agency’s budget has grown steadily since the 1960s, fueling an industry that creates lifesaving medicines and attracts ...
Discover what the next wave of AI-assisted drug discovery looks like and how it can help biotech - the AI and physics combo.
How BioRender and CEO Shiz Aoki are turning a standard visual language for biology into must-have AI infrastructure, from ...
While the 21st century has been bumpy, it has also ushered in monumental scientific and technological breakthroughs that have ...
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last year's ...
Mike Lawler (R-NY), and Scott Peters (D-CA) introduced the Childhood Diabetes Reduction Act, a bipartisan bill aimed at reducing childhood obesity and diet-related chronic diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results